Shares of Jyothy Labs fell 2.54% to ₹357.40 on the NSE on Monday, following the announcement of its Q4 FY25 results. The stock declined sharply in afternoon trade despite the company reporting stable earnings and improved margins.
For the quarter ended March 31, 2025, Jyothy Labs reported a consolidated net profit of ₹76.3 crore, slightly down from ₹78.2 crore in the same quarter last year. Revenue from operations stood at ₹667 crore, reflecting a modest YoY growth of 1.1%, while volume grew 4% during the period. The company’s EBITDA margin improved to 16.8% from 16.4% a year ago, aided by cost control and calibrated pricing.
For the full financial year, revenue rose 3.3% YoY to ₹2,847 crore, with EBITDA at ₹499.6 crore and margin expanding to 17.5%. Net profit for FY25 stood at ₹370.4 crore, marginally up from ₹369.3 crore in FY24.
The Board has recommended a final dividend of ₹3.5 per equity share.
While segments like Fabric Care and Dishwashing posted growth, Personal Care and Household Insecticides segments saw YoY declines in revenue. The company remains debt-free and held ₹757 crore in cash reserves as of March 31, 2025.
Despite the positive operational performance, weak consumer sentiment and muted urban demand continue to weigh on investor confidence, dragging the stock lower in today’s session.